© 1996 American Heart Association, Inc.
Articles |
Contrary Effects of Lightly and Strongly Oxidized LDL With Potent Promotion of Growth Versus Apoptosis on Arterial Smooth Muscle Cells, Macrophages, and Fibroblasts
From the Department of Pathology, Institute of Laboratory Medicine, Göteborg University, Sahlgrenska University Hospital, Göteborg, Sweden.
 |
Abstract |
|---|
 Top Abstract IntroductionMethods Results Discussion References |
|---|
Abstract The inhibition of experimental atherosclerosis by antioxidants and the presence of oxidized LDL (oxLDL) in atherosclerotic lesions indicate that oxLDL may play what is perhaps a primary role in atherogenesis. LDL promotes the growth of arterial smooth muscle cells (SMCs), and oxLDL has cytotoxic effects. Since excessive intimal growth alternating with necrosis is typical of atherosclerotic lesions, we wondered whether these extreme changes in the lesions could be related to the extreme effects of LDL and oxLDL on cells. We therefore examined the effects of increasing LDL oxidation on its capacity to induce cell growth or cell death and whether the latter could be due to apoptosis. Cells of the types present in the atherosclerotic artery were used, ie, SMCs (human arterial), macrophages (human macrophage-like cell line THP-1), and human fibroblasts. Growth was evaluated by measuring the synthesis of DNA and culture size (MTT method) and apoptosis by using the in situ labeling of internucleosomally degraded DNA and, in the case of SMCs, the appearance of chromatin condensation. The oxidation of LDL was mediated by UV or Fe ions. Shortly oxidized LDL had a markedly increased growth-promoting effect on all cell types. With prolonged exposure to UV, but not to Fe, LDL became increasingly cytotoxic, and this toxicity was paralleled by the appearance of apoptosis in all cell types. After prolonged UV treatment, low-molecular-weight material from the partially degraded LDL was responsible for the induction of apoptosis. The dual effect of oxLDL, ie, its strong growth-promoting effect or the induction of cell death by apoptosis, depending on the degree of change by oxidation, is compatible with the notion that oxLDL plays a role not only in atherogenesis but also more extensively in the development of the structure typical of the atherosclerotic lesion, with focal excessive growth alternating with necrosis.
Key Words: arterial smooth muscle cell • macrophage • cell growth • apoptosis • oxidized LDL
|
Introduction |
|---|
|
TopAbstractIntroductionMethods Results Discussion References |
|---|
The constituents of the body are continuously exposed to the risk of accidental oxidative damage. In addition, many components are very susceptible to oxidation, and this is especially true in the case of the unsaturated lipids of the membrane systems of the cell (for a review see Reference 1). More stable constituents, such as proteins and even nucleic acids, may also be damaged by oxidation. There are several lines of defense against oxidative damage in the form of multiple antioxidants in the tissues,2 and in normal circumstances, the effects of oxidative injury are not apparent. In certain pathological changes, such as atherosclerotic lesions (for a review see Reference 3), oxidatively changed material originating from LDLs that are especially sensitive to oxidation4 has been found. There is also good reason to suppose that oxLDL could in fact play a primary atherogenic role, as the supply of antioxidants appears to have an inhibitory effect on the development of experimental atherosclerosis (for a review see Reference 3).
It is well established that LDL promotes the growth of arterial SMCs and that oxidatively changed LDL has cytotoxic properties (for review see Reference 5). Excessive intimal growth alternating with focal massive cell death are characteristics typical of the atherosclerotic lesion,6 and the aim of this study was to investigate whether these extreme changes in the lesions could be related to the extreme effects of LDL and oxLDL on cells. The type of cell damage induced by oxLDL is not known, and an additional purpose of the study was to determine whether the cytotoxic reaction of oxLDL reflects nonspecific cell death or the possible induction of programmed cell death, apoptosis, in cells of the types present in the atherosclerotic artery.
The most important results of this study are that shortly oxidized LDL had a very powerful mitogenic effect that was many times greater than that of the parent unoxidized LDL. LDL oxidized for a longer period induced apoptosis in human arterial SMCs, in a macrophage cell line, and in human fibroblasts, ie, in cells of the types present in the atherosclerotic artery.
|
Methods |
|---|
|
TopAbstractIntroductionMethods Results Discussion References |
|---|
Cell Culture
Human arterial SMCs were obtained from aortic segments from young adult kidney donors (traffic accident victims). Small samples of the inner third of the media were obtained by microdissection under a stereomicroscope, and cultures were obtained by primary explantation as described in detail previously.7 8 9 10 In short, the primary explants were seeded onto fibronectin-coated flasks (15 µg/cm2) with 5% WBS in Williams' medium E (GIBCO) and Ham's medium F-12 (1:1), with 20 mmol of HEPES buffer, pH 7.3, 2.6 mmol of L-glutamine, 50 mg of neomycin, and 10 mg of ascorbic acid per liter. Serum fibronectin was isolated from plasma as described by Vuento and Vaheri.11 The cells were passaged by trypsinization, and further cultivation was performed in nutrition medium MCDB 104 (GIBCO), with 10% WBS and with L-glutamine and ascorbic acid, as above, and with 105 U of penicillin and 100 mg of streptomycin per liter. The SMCs were used up to the 7th passage.
Human fetal lung fibroblasts were obtained from Statens Bakteriologiska Laboratorium and used up to the 20th passage. They were cultivated in Ham's medium F-12 (GIBCO) with 5% donor calf serum and with penicillin, streptomycin, and ascorbic acid, as above.
The macrophage-like cell line THP-1 (acute monocytic leukemia, human) was obtained from American Type Culture Collection and was cultivated in RPMI 1640 (GIBCO), with 7.5% fetal calf serum and with L-glutamine, penicillin, and streptomycin, as above, with the addition of 2 mmol of sodium pyruvate (GIBCO) and 50 µmol of mercaptoethanol (E. Merck) per liter.
For experiments in which apoptosis was to be visualized by the in situ detection of internucleosomal DNA degradation or by DNA staining with gallocyanin-chrome alum stain (see below), the cells were plated onto chamber slides (Lab-Tek Chamber-slides, catalog No. 177445, Nunc Inc) that had been coated with plasma fibronectin11 (15 µg/cm2) and under the conditions described below for plating in multiwells.
Assays of Growth and Cytotoxic Effects
For growth
measurements, fibroblasts or SMCs detached by
trypsinization and THP-1 cells were suspended in Iscove's modified
Dulbecco's medium (GIBCO), which does not contain copper and iron
components, with 2.6 mmol of L-glutamate per liter, 100
µg of streptomycin, and 100 U of penicillin per milliliter. The
plating medium also contained 5% donor calf serum (GIBCO) for
fibroblasts and 3% human platelet-poor plasma
serum12 for SMCs and THP-1 cells. The cells were plated
into multiwells (96-well plates for tissue culture; Falcon) that were
coated with 15 µg/cm2 of fibronectin isolated from human
plasma.11 The number of cells plated was low enough (the
precise number is given in the description for each separate
experiment) to keep the cultures well under confluence during the
experiments. After 24 hours, the platelet-poor plasma
serum–containing medium was changed to serum- and plasma-free
medium, and the cells were incubated for at least 72 hours to obtain
quiescence. For this purpose, Iscove's medium was used with 2.6 mmol
of L-glutamate, 100 mg of streptomycin, 105
U of penicillin, 10 mg of transferrin (Collaboratory Research), and 2 g
of ovalbumin per liter (Grade V, Sigma). For the subsequent
period of exposure to samples, this medium was used, with the addition
of 5 µg of cholesterol per milliliter (purified by
chromatography on aluminum oxide5 ).
For studies of DNA replication, the cultures were exposed to the samples and to 5 µCi of methyl[3H]thymidine (NET-027, NEN, DuPont) per well for 24 hours, after which the cells were detached by trypsinization and loaded onto a glass filter by using a cell harvester. The activity was measured by liquid scintillation counting.
The culture size was determined by measuring mitochondrial activity using the MTT method, as described,5 13 by the reduction of MTT to blue formazan product. In short, a solution of MTT in PBS (5 mg/mL) was added to each well culture, and the cultures were incubated for 5 hours. When MTT is reduced, it is converted to blue formazan crystals during incubation. After incubation, these crystals were dissolved by adding SDS during an additional incubation period of 16 hours. The absorbency was read at 590 nm in an enzyme immunoassay multiwell photometer. Growth, as measured by the MTT method, was recorded as the net increase in absorbency after the subtraction of the background absorbency and expressed as "MTT units." Control experiments, described in a previous report,5 had shown that there was a direct and linear relationship between the number of cells and the MTT values.
Isolation and Fractionation of Serum Lipoproteins
The serum
lipoproteins were isolated and fractionated with
density gradient ultracentrifugation in sodium
bromide density solutions, as previously described in
detail.5 14 The lipoproteins were protected from
proteolytic degradation and from oxidation by a number of proteolytic
inhibitors, bacteriocide, EDTA, and an antioxidant (BHT)
during the entire isolation and fractionation procedure, which was
carried out at 10°C.
Total lipoproteins were isolated by density-cushion ultracentrifugation at 302 000g max for 26 hours in a Beckman L8M ultracentrifuge with an angle rotor (50.2 Ti), essentially as described by Rudel et al,15 with minor modifications.5 The total lipoproteins were further fractionated by density-gradient ultracentrifugation at 288 000g max for 22 hours in a swinging-out rotor (SW 41 Ti, Beckman). The density gradient was shaped by layering density cushions to cover a density range of 1.06 to 1.21, as described by Pitas and Mahley.16 If not used within 2 days, the lipoprotein fractions were stored at -135°C under nitrogen after cryopreservation, as described by Rumsey et al.17 18 LDL was measured by its content of protein, with a modification19 of the method described by Lowry et al.20
Oxidation of LDL and Fractionation of OxLDL
LDL was oxidized
by exposure to UV light at 257 nm with an
intensity of 1 mW/cm2 (Osram HNF 200 W and a 16-cm distance
between sample cuvette and lamp). Before exposure to UV light, the LDL
was extensively dialyzed in a Pierce microdialysis
apparatus at 4°C against 5 mmol of Tris buffer, pH 7.4,
per liter in saline followed by saline or against PBS during the whole
dialysis for experiments with unfractionated oxLDL. For experiments in
which oxLDL was fractionated into a low-molecular-weight and
high-molecular-weight fraction, LDL was dialyzed against a
volatile buffer, viz 0.15 mol of ammonium bicarbonate buffer, pH 7.8
per liter, to remove EDTA and nonvolatile buffer material. The buffer
solutions had been deoxygenated with oxygen-free
nitrogen. Before exposure to UV, the dialyzed LDL was diluted with
respective buffer to a protein concentration of 
0.25 mg/mL and
transferred to a quartz cuvette.
The oxidation of LDL mediated by Fe ions was carried out as follows. LDL was extensively dialyzed in a Pierce microdialysis apparatus at 4°C against buffered saline followed by saline, as described above. The concentration of LDL was adjusted to 0.25 mg of protein per milliliter and FeCl3 added, to 0.2 mmol/L concentration, and the sample was incubated at +37°C for the periods indicated for each experiment.
The oxidation was monitored by the TBARS method, as described by Wallin et al21 and by the increased motility of oxLDL in agarose electrophoresis.22 The latter was performed with a kit for agarose gel electrophoresis for the diagnostic determination of lipoproteins (Hydragel LIPO+Lp(a); Sebia) and used under the conditions recommended by the manufacturer.
Changes induced by exposure to UV light were also examined by using PAGE with minigels (PhastGel gradients 4 to 15 or 8 to 25), using the Phast-System (Pharmacia LKB Biotechnology) as recommended by the manufacturer and with inclusion of appropriate molecular-weight standards (high and low range, Bio-Rad; polypeptides, Pharmacia Biotech). The gels were silver stained using procedures slightly modified from that described by Heukeshoven and Dernick23 and as recommended by the manufacturer of the gels.
High- and low-molecular-weight derivatives of LDL on oxidation were separated by ultrafiltration with an Amicon ultrafiltration device with filter cutoff of 30 000 D (YM30, Amicon Division, W.R. Grace & Co). The low-molecular fraction was concentrated in a vacuum in a Speed-Vac (Hetovac, VR-1, Heto-Holten), by which excessively volatile buffer material was also eliminated.
Extraction and Fractionation of LDL Lipids
The lipid
component of LDL was extracted as described by Bligh
and Dyer,24 as modified by Parthasarathy et
al,25 with the addition of BHT to the
solvents26 to avoid oxidation. LDL corresponding to 2
milligrams of protein was exhaustively dialyzed in a Pierce
microdialysis device against PBS and diluted to 2.2 mL with PBS.
Ice-cooled methanol (2.0 mL) with 0.1% BHT was rapidly added to
1.8 mL of the chilled LDL material in a glass centrifuge tube,
the mixture was vortexed, 2.0 mL of ice-cooled chloroform was
added, and the contents were once again mixed by vortexing. The mixture
was centrifuged at 4°C, 1800g for 10 minutes, and
the subnatant layer, which contained the lipids, was collected. The
solvent was evaporated under oxygen-free nitrogen, and the lipids
were dissolved in toluene and stored under nitrogen, at 4°C in the
dark. For experiments on the distribution of
apoptosis-inducing material in the methanol-water phase
and the subnatant, lipid phase, the phases were collected and washed
with chloroform and methanol-water, respectively. The
methanol-water phase was concentrated in a vacuum in a Speed-Vac
and the lipid phase under oxygen-free nitrogen, as described above.
The total LDL lipids were further fractionated into neutral lipids and phospholipids with chromatography on silicic acid.27 In short, the total lipids were dried under nitrogen and redissolved in 2.0 mL methyl-tert-butyl ether/hexane (1:9) and applied to a silica Sep-Pak cartridge (Sep-Pak Classic Silica, catalog No. 51900, Millipore Intertech) preequilibrated with hexane. The neutral lipids were eluted with 20 mL of methyl-tert-butyl ether/hexane (1:1) and the phospholipids with 20 mL methanol. For incubation with cells, the total lipids and the lipid fractions were dried under nitrogen and suspended in PBS with 2% lipid-free bovine serum albumin (A8806, Sigma) by vigorous vortexing under nitrogen and with slight warming. Before use, the albumin solution in PBS had been neutralized.
Detection of Apoptosis
Detection of Internucleosomal
DNA Fragmentation With Methods for
the In Situ Labeling of Degraded DNA
In the first part of this study,
in situ nonisotopic
labeling techniques for apoptosis involving avidin-biotin
binding28 29 were used, but the reproducibility was
not
satisfactory with our material and in our hands. We therefore applied a
technique involving the template-independent addition by terminal
deoxynucleotidal transferase (TdT) of digoxigenin-dUTP to 3'-OH DNA
ends generated by the internucleosomal degradation of DNA in
apoptosis (TdT-mediated dUTP nick end labeling [TUNEL]) and
the visualization of the digoxigenin-labeled DNA by direct
immunoperoxidase detection (ApopTag, Oncor).
Detection of
Light-Microscopic Nuclear Changes in
Apoptosis
The standard May-Grünwald-Giemsa method has been used
for
the detection of apoptosis in cell cultures, especially for
cells that do not exhibit endonuclease activity in conjunction with
apoptosis, such as nontransformed vascular
SMCs.30 31 The human arterial SMCs flatten out
very strongly in the cultures, and the staining of the very attenuated
cells with May-Grünwald-Giemsa was too weak and indistinct for
our purpose to permit the detection of apoptosis.
Different specific DNA-staining techniques were therefore tried. Staining of DNA with Einarson's gallocyanin-chrome alum method32 was found to be satisfactory. It was performed essentially as previously described33 with cultures on chamber slides fixed in cacodylate-buffered formalin solution prepared from paraformaldehyde.34 The staining solution was prepared with 5 g of chrome alum and 0.15 g of gallocyanin in 100 mL of distilled water that was boiled for 5 minutes, cooled, and filtered (final pH 1.64). The volume was adjusted to 100 mL and staining was performed for 96 hours at room temperature.
Apoptotic
cells were counted as follows. The counting was
guided by a grid mounted in one of the oculars and covering 80% of
the microscope field. Apoptotic cells contained within the grid
were counted, and the grid was then moved to a new field. Approximately
500 cells were counted for each chamber culture, and care was taken to
cover the culture as evenly as possible.
|
Results |
|---|
|
TopAbstractIntroductionMethods Results Discussion References |
|---|
Low-density lipoprotein is sensitive to oxidation,3 and there is evidence of the presence of oxidized LDL in vivo both in plasma and in atherosclerotic lesions.4 The oxidation of LDL is accelerated in the presence of ions of transition metals such as Fe and Cu and by exposure to UV light (for a review see Reference 3). A certain selectivity for the oxidation of the protein and the lipid component with treatment with Fe and UV, respectively, has been reported.35 We wondered whether this behavior might also be reflected in selectivity in terms of the biological effects of material formed from LDL treated with Fe or UV. LDL was treated with Fe or UV for different periods of time, and the effect of the oxLDL was tested on fibroblast cultures (Fig 1
). With a relatively short period of exposure to
Fe or UV, oxLDL exhibited a far more pronounced growth-promoting
effect than native LDL (Fig 1). With prolonged exposure to UV,
this
effect decreased and changed to a cytotoxic effect. With prolonged
exposure to Fe, LDL essentially maintained its strong
growth-promoting capacity, and cytotoxic effects were not
observed.
|
The development of TBARS is shown in Fig 2A. With Fe,
TBARS developed more rapidly and reached a higher concentration than
with UV treatment. Consequently, there was no relationship between the
development of TBARS and the degree of cytotoxicity. As evaluated with
SDS-PAGE of UV-treated LDL (Fig 2B),
very-high-molecular-weight, intact apoB decreased as the
duration of treatment increased, with the formation of degradation
products of varying molecular sizes. With prolonged exposure (25
hours), almost all the medium-sized molecules also disappeared, and
fairly small amounts of very-high-molecular-weight material
(apoB) remained (Fig 2B).
|
The cytotoxic effects of oxLDL on fibroblasts (Fig 1
) were
very
pronounced in the case of LDL exposed to UV, in contrast to that of LDL
treated with Fe. The exposure of LDL to UV in the specified conditions
(see "Methods") for 25 hours was therefore chosen for the studies
of the induction of apoptosis. Fig 3 illustrates
the effect of LDL exposed to UV for different time intervals on the
replication of DNA in fibroblasts and the macrophage-like
cell line THP-1. Replication was stimulated for both cell types by LDL
exposed to UV for short and moderately long time intervals. After
prolonged UV treatment, the synthesis of DNA was reduced, thus
indicating cytotoxicity. In the same way as for the fibroblasts (Fig
1), analogous results were obtained with the
macrophage-like cell line for the effects on culture size
(Fig 4). The macrophages were more sensitive to
the cytotoxic effects of oxLDL than the fibroblasts, as demonstrated by
the reduction in culture size and the replication of the former, even
with LDL that had been exposed to UV during a somewhat short time
interval (Figs 1, 3, and 4).
|
|
Apoptosis could be readily visualized in fibroblasts and in the
macrophage-like cell line THP-1 by the in situ staining of
the internucleosomal degradation of DNA. The combination with
phase-contrast microscopy also permitted the detection of other
signs of apoptosis such as blebbing, retraction, and
fragmentation. Fig 5 shows micrographs in the phase
contrast (Fig 5A) and light field (Fig 5B) of
chamber-slide
fibroblast cultures that had been exposed to UV-oxLDL at a
concentration corresponding to 400 µg of parent LDL per milliliter
and fixed and stained for internucleosomal DNA degradation. The
numerical values for the appearance of apoptosis at different
concentrations of oxLDL in this experiment are given in Table
1.
|
|
The internucleosomal degradation of DNA could not be detected in
arterial SMCs by agarose electrophoresis of the extracted
DNA (not shown) or by the in situ staining of internucleosomally
degraded DNA, in agreement with other reports.30 31
Apoptosis could be readily detected, however, from chromatin
condensation visualized by staining DNA using the
gallocyanin-chrome alum method (Fig 6). Even the
degree of chromatin condensation could be roughly estimated. In an
experiment with graded exposure to oxLDL, the degree of chromatin
condensation was roughly proportional to the concentration of oxLDL in
the culture medium (Fig 6A through 6D). Additional information
on
changes indicating apoptosis could be obtained by combination
with phase-contrast microscopy (see above).
|
The effect on fibroblasts of exposure to increasing concentrations of
low- and high-molecular derivatives of oxLDL is shown in Table
1.
Apoptosis was visualized by the in situ staining of the
internucleosomal degradation of DNA. The incidence of apoptotic
cells increased gradually as the concentration of low-molecular
derivatives of oxLDL increased and reached a level of 10% at the
highest concentration of low-molecular oxLDL derivatives. Exposure
to the high-molecular fraction of oxLDL was not followed by the
appearance of apoptotic cells.
The incidence of apoptosis in SMCs in ordinary cultures without
oxLDL and in the presence of 10% WBS was slightly higher than 1%, as
evaluated from the appearance of chromatin condensation with
gallocyanin-chrome alum stain (Table 2). Lipids from
native unoxidized LDL apparently did not promote apoptosis in
SMCs even at concentrations corresponding to high levels of unoxidized
LDL (Table 2).
|
As for the fibroblasts (Table 1), oxLDL induced apoptosis in
SMCs (Table 3), and this capacity was confined to the
low-molecular derivatives of oxLDL. The effect on SMCs was very
marked, and at the highest concentration of low-molecular oxLDL
derivatives, all cells were apoptotic (Table 3).
|
Exposure of SMCs to the low-molecular fraction of oxLDL under
serum-free conditions had a stronger apoptosis-inducing
effect than in the presence of 10% WBS (Table 4).
|
OxLDL was separated into a water-methanol and a chloroform (lipid-soluble) fraction by phase separation during the extraction of lipids from oxLDL, but the apoptosis-inducing effect of the fractions was not clearly different (not shown).
|
Discussion |
|---|
|
TopAbstractIntroductionMethods Results Discussion References |
|---|
There is a distinct relationship between oxidative stress and the induction of programmed cell death, apoptosis. Many oxidants initiate apoptosis and several antioxidants inhibit it.36 There are several lines of defense against unwanted oxidation in tissues and cells, and overt manifestations of oxidation in tissue components are rare under normal conditions. In some pathological states, however, such as atherosclerosis, the effects of uncontrolled oxidation are more apparent, and it has even been suggested that they play a pathophysiological role in the development of the disease. Irregular metabolism of LDL is strongly related to the development of atherosclerosis, and recent evidence suggests that this phenomenon may be mediated by effects from the uncontrolled oxidation of LDL (for a review see Reference 4). There is, in fact, direct evidence of the presence of oxLDL in plasma37 and in atherosclerotic lesions.37 38 The focal excessive death of arterial tissue is very prominent in atherosclerotic lesions, and one of the aims of the present work was to elucidate whether this process could be due to the effects of oxLDL, possibly by the induction of apoptosis.
A wide variety of methods have been used for the experimental oxidation of LDL. Oxidation is commonly promoted by exposure to UV light35 39 40 or to transition metal ion–mediated oxidation with Fe or Cu ions (for a review see Reference 4). Exposure to UV light was found to be far more effective when it came to the production of cytotoxic and apoptosis-inducing material from LDL than exposure to Fe ions, and the former method was therefore used for LDL oxidation in the present work.
The detection of apoptosis by using extracted DNA material was not suitable for the present purpose, but the in situ staining was very useful, except for SMCs in which the internucleosomal degradation of DNA did not accompany the structural changes of apoptosis.30 41 For this cell type, we applied the gallocyanin-chrome alum stain for DNA to visualize the condensation of the chromatin as an indication of apoptosis. This method proved to be very sensitive and permitted a semiquantitative assessment of the degree of chromatin condensation.
Relatively short exposure of LDL to UV or Fe ions increased the mitogenic effect of oxLDL to several times that of the native LDL. This effect was preserved even after the prolonged treatment of LDL with Fe. The fact that oxidation strongly increased the mitogenicity of LDL for SMCs and for macrophages may be a very important observation pathophysiologically. The increased growth of SMCs is regarded as a key mechanism for the development of intimal thickening and for the development of the thickened intima to a fibroatheroma or fibrous plaque. Macrophages tend to clear away accumulations of lipoproteins to become foam cells, and many of them may end up as cell debris and extracellular lipids to add instability to the atherosclerotic plaque. These changes are important components of the atherogenic process (for a review see References 6 and 42), and the above-mentioned results of the present work may therefore contribute to a pathophysiological explanation for one of the potential roles of oxLDL in atherogenesis. There could be several mechanisms underlying the strongly increased mitogenicity of shortly oxidized LDL. It has recently been shown that the mitogenic and growth-promoting effects of native, unoxidized LDL require the presence of LDL receptors.14 It is known that lightly oxidized LDL, in contrast to native LDL, may be internalized by multiple receptor-mediated pathways (for a review see Reference 3), which could increase the efficiency of internalization and thereby the effects on the cells. In addition, there is evidence that low concentrations of oxLDL may increase the production of PDGF-AA and the expression of PDGF receptors in SMCs and could thereby perhaps increase growth by autocrine stimulation.43
The cytotoxic effects of experimentally oxidized LDL and even of LDL that had not been intentionally oxidized have been described in many reports,5 40 43 44 45 46 47 48 but the nature of the cell death has not been clarified. Death by apoptosis induced by various means in vitro has been reported for macrophages49 50 51 52 53 and fibroblasts (for a review see Reference 54) of different origins and for arterial SMCs.30 31 55 Little information is available on the apoptosis-inducing effects of oxLDL. OxLDL was found to induce apoptosis in a macrophage-like murine cell line,49 in mouse peritoneal macrophages,50 and in lymphoblastoid cells.56 57 To our knowledge, no data on the apoptosis-inducing effects of oxLDL on arterial SMCs and fibroblasts have previously been presented. Sparse information is available on the occurrence of apoptosis in conditions more like those in the arterial wall in vivo. The occurrence of apoptosis was reported for reconstituted (spheroidal) human arterial smooth muscle tissue55 and for SMCs in human saphenous vein grafts.58 Evidence was recently presented for the occurrence of apoptosis in atherosclerotic lesions.59 60 Apoptosis has been described for myofibroblasts in granulation tissue,61 which have many properties in common with the modulated, synthetic phenotype of the arterial SMCs.
The generation of cytotoxic and apoptosis-inducing material on prolonged UV treatment was related to the degradation of apoB to low-molecular-weight material, in agreement with several reports on the oxidative degradation of apoB after various types of oxidative treatment.25 35 62 63 The results of the present study clearly demonstrate that the prolonged oxidation of LDL promoted by UV generates derivatives with apoptosis-inducing effects in SMCs, in a macrophage line and in fibroblasts. The apoptosis-inducing effect was confined to the low-molecular-weight material after prolonged exposure to UV.
Apoptosis was induced in vitro at a concentration of oxLDL material corresponding to slightly above the concentration of LDL in the interstitial fluid (100 to 150 µg of apoB per milliliter64 ). This is clearly within the pathophysiological range for the arterial wall tissue, especially in certain atherogenic situations such as endothelial injury or hyperlipidemic states.
Serum had a protective effect on apoptosis (Table 4), in
agreement with other studies in which serum65 or growth
factors in serum, such as insulin-like growth
factor-I66 and PDGF,67 inhibited the
appearance of apoptosis. Since oxLDL contained both lipid- and
water-soluble components with the capacity to induce
apoptosis, it was not possible to conclude from the present
results whether the apoptosis-inducing material was derived
from the lipid68 or the apoB component of LDL.
Proliferative tissue changes alternating with necrosis are apparent in atherosclerotic lesions. Such changes are the basis of several of the most severe complications of atherosclerosis, such as arterial stenosis or arterial rupture with hemorrhage or plaque rupture or fissuring with mural hemorrhage, atheroembolism, and/or thrombosis with subsequent occlusion. OxLDL is currently believed to play an important atherogenic role. The dual effect of oxLDL, ie, its strong growth-promoting effect or the induction of cell death by apoptosis, depending on the degree of change by oxidation, as demonstrated in this report is compatible with the conclusion that oxLDL plays a role not only in atherogenesis but also more extensively in the development of the structure typical of the atherosclerotic lesion and thereby contributes to the important clinical effects of the lesion.
|
Selected Abbreviations and Acronyms |
|---|
|
|
Acknowledgments |
|---|
This study was supported by the Swedish Medical Research Council (project No. 2589) and by the LUA fund of the Medical Faculty of the Göteborg University. The authors thank Eva Carlsson for excellent technical assistance.
|
Footnotes |
|---|
Reprint requests to Sören Björkerud, MD, PhD, Department of Pathology, Sahlgrenska University Hospital, S-413 45, Göteborg, Sweden.
Received May 8, 1995; accepted November 7, 1995.
|
References |
|---|
|
TopAbstractIntroductionMethods Results Discussion References |
|---|
1. Schimke I, Haberland A. Oxygen radicals and diseases of the heart and circulatory system: pathogenetic mechanisms, therapeutic possibilities. Z Kardiol. 1993;82:601-609. [Medline] [Order article via Infotrieve]
2. Manson JE, Gaziano JM, Jonas MA, Hennekens CH. Antioxidants and cardiovascular disease: a review. J Am Coll Nutr. 1993;12:426-432. [Abstract]
3. Penn MS, Chisolm GM. Oxidized lipoproteins, altered cell function and atherosclerosis. Atherosclerosis. 1994;108:S21-S29.
4. Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet. 1994;344:793-795. [Medline] [Order article via Infotrieve]
5.
Björkerud S, Björkerud B.
Lipoproteins are major and primary mitogens and growth promoters for
human arterial smooth muscle cells and lung fibroblasts in
vitro. Arterioscler Thromb. 1994;14:288-298.
6. Gotlieb AI, Havenith MG. Atherosclerosis: lesions and pathogenesis. In: Silver MD, ed. Cardiovascular Pathology. 2nd ed. New York, NY: Churchill Livingstone; 1991:225-265.
7.
Björkerud S. Effects of transforming
growth factor-ß1 on human arterial smooth muscle cells in
vitro. Arterioscler Thromb. 1991;11:892-902.
8. Björkerud S. Separation of arterial smooth muscle cell subpopulations with different growth patterns. Acta Pathol Microbiol Immunol Scand (A). 1984;92:293-301. [Medline] [Order article via Infotrieve]
9. Björkerud S. Cultivated human arterial smooth muscle displays heterogeneous pattern of growth and phenotypic variation. Lab Invest. 1985;53:303-310. [Medline] [Order article via Infotrieve]
10. Björkerud S. Agglomeration to nodules modulates human arterial smooth muscle cells to distinct postinjury phenotype via foam cell transition. Am J Pathol. 1987;127:485-498. [Abstract]
11. Vuento M, Vaheri A. Purification of fibronectin from human plasma by affinity chromatography under non-denaturating conditions. Biochem J. 1979;183:331-337. [Medline] [Order article via Infotrieve]
12.
Rutherford RB, Ross R. Platelet factors
stimulate fibroblasts and smooth muscle cells quiescent in plasma to
proliferate. J Cell Biol. 1976;69:196-203.
13. Kotnik V, FleischmannWR Jr. A Simple and rapid method to determine hematopoietic growth factor activity. J Immunol Methods. 1990;129:23-30. [Medline] [Order article via Infotrieve]
14. Björkerud S, Björkerud B. Growth-stimulating effect of lipoproteins on human arterial smooth muscle cells and lung fibroblasts is due to Apo-B containing lipoproteins, type LDL and VLDL, and requires LDL-receptors. Biochim Biophys Acta. 1995;1268:237-247. [Medline] [Order article via Infotrieve]
15. Rudel LL, Marzetta CA, Johnson FL. Separation and analysis of lipoproteins by gel filtration. Methods Enzymol. 1986;129:45-57. [Medline] [Order article via Infotrieve]
16. Pitas RE, Mahley RW. Analysis of tissue lipoproteins. In: Converse CA, Skinner ER, eds. Lipoprotein Analysis: A Practical Approach. Oxford, UK: IRL Press at Oxford University Press; 1992:215-242.
17. Rumsey SC, Galeano NF, Arad Y, Deckelbaum RJ. Cryopreservation with sucrose maintains normal physical and biological properties of human plasma low density lipoproteins. J Lipid Res. 1992;33:1551-1561. [Abstract]
18. Rumsey SC, Stucchi AF, Nicolosi RJ, Ginsberg HN, Ramakrishnan R, Deckelbaum RJ. Human plasma LDL cryopreserved with sucrose maintains in vivo kinetics indistinguishable from freshly isolated human LDL in cynomolgus monkeys. J Lipid Res. 1994;35:1592-1598. [Abstract]
19. Maxwell MAK, Hars SM, Bieber LL, Tolbert NE. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem. 1978;87:206-210. [Medline] [Order article via Infotrieve]
20.
Lowry O, Rosenbrough N, Farr A, Randall R.
Protein measurement with the Folin phenol reagent.
J Biol Chem. 1951;193:265-275.
21. Wallin B, Rosengren B, Shertzer HG, Camejo G. Lipoprotein oxidation and measurement of thiobarbituric acid reacting substances formation in a single microtiter plate: its use for evaluation of antioxidants. Anal Biochem. 1993;208:10-15. [Medline] [Order article via Infotrieve]
22. Hoff HF, Gaubatz JW. Isolation, purification, and characterization of a lipoprotein containing apo B from the human aorta. Atherosclerosis. 1982;42:273-297. [Medline] [Order article via Infotrieve]
23. Heukeshoven J, Dernick R. Simplified method for silver staining of proteins in polyacrylamide gels and the mechanism of silver staining. Electrophoresis. 1985;6:103-112.
24. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37:911-917.
25.
Parthasarathy S, Fong LG, Otero D, Steinberg D.
Recognition of solubilized apoproteins from delipidated, oxidized low
density lipoprotein (LDL) by the acetyl-LDL receptor.
Proc Natl Acad Sci U S A. 1987;84:537-540.
26. Pacifici EHK, McLeod LL, Peterson H, Sevanian A. Linoleic acid hydroperoxide-induced peroxidation of endothelial cell phospholipids and cytotoxicity. Free Radic Biol Med. 1994;17:285-295. [Medline] [Order article via Infotrieve]
27. Folcik VA, Cathcart MK. Predominance of esterified hydroperoxy-linoleic acid in human monocyte-oxidized LDL. J Lipid Res. 1994;35:1570-1582. [Abstract]
28.
Gavrieli Y, Sherman Y, Bensasson SA.
Identification of programmed cell death in situ via specific labeling
of nuclear DNA fragmentation. J Cell Biol. 1992;119:493-501.
29. Wijsman JH, Jonker RR, Keijzer R, Van de Velde CJH, Cornelisse CJ, Van Dierendonck JH. A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA. J Histochem Cytochem. 1993;41:7-12. [Abstract]
30.
Bennett MR, Evan GI, Newby AC. Deregulated
expression of the c-myc oncogene abolishes inhibition of
proliferation of rat vascular smooth muscle cells by serum reduction,
interferon-gamma, heparin, and cyclic nucleotide
analogues and induces apoptosis. Circ
Res. 1994;74:525-536.
31. Leszczynski D, Zhao YJ, Luokkamaki M, Foegh ML. Apoptosis of vascular smooth muscle cells: protein kinase C and oncoprotein Bcl-2 are involved in regulation of apoptosis in non-transformed rat vascular smooth muscle cells. Am J Pathol. 1994;145:1265-1270. [Abstract]
32. Einarson L. On the theory of gallocyanin-chromalum staining and its application for quantitative estimation of basophilia: a selective staining of exquisite progressivity. Acta Pathol Microbiol Scand. 1951;28:82-102. [Medline] [Order article via Infotrieve]
33. Lillie RD, Fullmer HM. Histopathologic Technique and Practical Histochemistry. 4th ed. New York, NY: McGraw-Hill Inc; 1976:212-213.
34. Karnovsky MJ. A formaldehyde-glutaraldehyde fixative of high osmolality for use in electron microscopy. J Cell Biol. 1965;27:137A-138A. Abstract.
35. Dousset N, Negre-Salvayre A, Lopez M, Salvayre R, Douste-Blazy L. Ultraviolet-treated lipoproteins as a model system for the study of the biological effects of lipid peroxides on cultured cell, I: chemical modifications of ultraviolet-treated low-density lipoproteins. Biochim Biophys Acta. 1990;1045:219-223. [Medline] [Order article via Infotrieve]
36. Buttke TM, Sandstrom PA. Oxidative stress as a mediator of apoptosis. Immunol Today. 1994;15:7-10. [Medline] [Order article via Infotrieve]
37.
Palinski W, Rosenfeld ME, Ylä-Herttuala S,
Gurtner GC, Socher SS, Butler SW, Parthasarathy S, Carew TE, Steinberg
D, Witztum JL. Low density lipoprotein undergoes oxidative modification
in vivo. Proc Natl Acad Sci U S A. 1989;86:1372-1376.
38.
Haberland ME, Fong D, Cheng L.
Malondialdehyde-altered protein occurs in atheroma of
Watanabe heritable hyperlipidemic rabbits.
Science. 1988;241:215-218.
39. Paillous N, Feryforgues S. Interest of photochemical methods for induction of lipid peroxidation. Biochimie. 1994;76:355-368. [Medline] [Order article via Infotrieve]
40. Alomar Y, Negre-Salvayre A, Levade T, Valdiguie P, Salvayre R. Oxidized HDL are much less cytotoxic to lymphoblastoid cells than oxidized LDL. Biochim Biophys Acta. 1992;1128:163-166. [Medline] [Order article via Infotrieve]
41. Cohen GM, Sun XM, Snowden RT, Dinsdale D, Skilleter DN. Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem J. 1992;286:331-334.
42. Schwartz CJ, Valente AJ, Sprague EA. A modern view of atherogenesis. Am J Cardiol. 1993;71:B9-B14.
43.
Stiko-Rahm A, Hultgårdh-Nilsson A, Regnström J,
Hamsten A, Nilsson J. Native and oxidized LDL enhances
production of PDGF-AA and the surface expression of PDGF
receptors in cultured human smooth muscle cells.
Arterioscler Thromb. 1992;12:1099-1109.
44. Hessler JR, Robertson ALJ Jr, Chisolm GM III. LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. Atherosclerosis. 1979;32:213-229. [Medline] [Order article via Infotrieve]
45.
Gospodarowicz D, Hirabayashi K, Giguère L, Tauber
J-P. Factors controlling the proliferative rate, final cell
density, and life span of bovine vascular smooth muscle cells in
culture. J Cell Biol. 1981;89:568-578.
46. Libby P, Mioa P, Ordovas JM, Schaefer EJ. Lipoproteins increase growth of mitogen-stimulated arterial smooth muscle cells. J Cell Physiol. 1985;124:1-8. [Medline] [Order article via Infotrieve]
47. Chen J-K, Hoshi H, McClure DB, McKeehan WL. Role of lipoproteins in growth of human adult arterial endothelial and smooth muscle cells in low lipoprotein-deficient serum. J Cell Physiol. 1986;129:207-214. [Medline] [Order article via Infotrieve]
48. Thomas JP, Geiger PG, Girotti AW. Lethal damage to endothelial cells by oxidized low density lipoprotein: role of selenoperoxidases in cytoprotection against lipid hydroperoxide-mediated and iron-mediated reactions. J Lipid Res. 1993;34:479-490. [Abstract]
49. Reid VC, Hardwick SJ, Mitchinson MJ. Fragmentation of DNA in P388D(1) macrophages exposed to oxidised low-density lipoprotein. FEBS Lett. 1993;332:218-220. [Medline] [Order article via Infotrieve]
50. Reid VC, Mitchinson MJ, Skepper JN. Cytotoxicity of oxidized low-density lipoprotein to mouse peritoneal macrophages: an ultrastructural study. J Pathol. 1993;171:321-328. [Medline] [Order article via Infotrieve]
51. Albina JE, Cui SJ, Mateo RB, Reichner JS. Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J Immunol. 1993;150:5080-5085. [Abstract]
52. Richardson BC, Lalwani ND, Johnson KJ, Marks RM. Fas ligation triggers apoptosis in macrophages but not endothelial cells. Eur J Immunol. 1994;24:2640-2645. [Medline] [Order article via Infotrieve]
53.
Munn DH, Beall AC, Song D, Wrenn RW, Throckmorton
DC. Activation-induced apoptosis in human
macrophages: developmental regulation of a novel cell death
pathway by macrophage colony-stimulating factor acid
interferon gamma. J Exp Med. 1995;181:127-136.
54. Bayreuther K, Francz PI, Rodemann HP. Fibroblasts in normal and pathological terminal differentiation, aging, apoptosis and transformation. Arch Gerontol Geriatr. 1992;47-74.
55.
Björkerud S, Björkerud B, Joelsson
M. Structural organization of reconstituted human
arterial smooth muscle tissue.
Arterioscler Thromb. 1994;14:644-651.
56. Escargueil I, Négre-Salvayre A, Pierraggi MT, Salvayre R. Oxidized low density lipoproteins elicit DNA fragmentation of cultured lymphoblastoid cells. FEBS Lett. 1992;305:155-159. [Medline] [Order article via Infotrieve]
57. Escargueil-Blanc I, Salvayre R, Négre-Salvayre A. Necrosis and apoptosis induced by oxidized low density lipoproteins occur through two calcium-dependent pathways in lymphoblastoid cells. FASEB J. 1994;8:1075-1080. [Abstract]
58. Kockx MM, Cambier BA, Bortier HE, De Meyer GR, Declercq SC, Van Cauwelaert PA, Bultinck J. Foam cell replication and smooth muscle cell apoptosis in human saphenous vein grafts. Histopathology. 1994;25:365-371. [Medline] [Order article via Infotrieve]
59. Geng YJ, Libby P. Evidence for apoptosis in advanced human atheroma: colocalization with interleukin-1 beta-converting enzyme. Am J Pathol. 1995;147:251-266. [Abstract]
60. Han DKM, Haudenschild CC, Hong MK, Tinkle BT, Leon MB, Liau G. Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am J Pathol. 1995;147:267-277. [Abstract]
61. Desmouliere A, Redard M, Darby I, Gabbiani G. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol. 1995;146:56-66. [Abstract]
62. Hoff HF, O'Neil J. Structural and functional changes in LDL after modification with both 4-hydroxynonenal and malondialdehyde. J Lipid Res. 1993;34:1209-1217. [Abstract]
63. Noguchi N, Gotoh N, Niki E. Dynamics of the oxidation of low density lipoprotein induced by free radicals. Biochim Biophys Acta. 1993;1168:348-357. [Medline] [Order article via Infotrieve]
64. Reichl D. Extravascular circulation of lipoproteins: their role in reverse transport of cholesterol. Atherosclerosis. 1994;105:117-129. [Medline] [Order article via Infotrieve]
65. Kulkarni GV, McCulloch CAG. Serum deprivation induces apoptotic cell death in a subset of balb/c 3T3 fibroblasts. J Cell Sci. 1994;107:1169-1179. [Abstract]
66.
Sell C, Baserga R, Rubin R. Insulin-like
growth factor I (IGF-I) and the IGF-I receptor prevent
etoposide-induced apoptosis. Cancer Res. 1995;55:303-306.
67. Harrington EA, Bennett MR, Fanidi A, Evan GI. c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J. 1994;13:3286-3295. [Medline] [Order article via Infotrieve]
68. Esterbauer H. Cytotoxicity and genotoxicity of lipid-oxidation products. Am J Clin Nutr. 1993;57:S779-S786.
This article has been cited by other articles:
 |
|
 |
|
  M. Groeneweg, E. Kanters, M. N. Vergouwe, H. Duerink, G. Kraal, M. H. Hofker, and M. P. J. de Winther Lipopolysaccharide-induced gene expression in murine macrophages is enhanced by prior exposure to oxLDL J. Lipid Res., October 1, 2006; 47(10): 2259 - 2267. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Isobe, S. Tsimikas, J. Zhou, S. Fujimoto, M. Sarai, M. J. Branks, A. Fujimoto, L. Hofstra, C. P. Reutelingsperger, T. Murohara, et al. Noninvasive Imaging of Atherosclerotic Lesions in Apolipoprotein E-Deficient and Low-Density-Lipoprotein Receptor-Deficient Mice with Annexin A5 J. Nucl. Med., September 1, 2006; 47(9): 1497 - 1505. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. X.-F. Deng, J. M. Spin, A. Tsalenko, A. Vailaya, A. Ben-Dor, Z. Yakhini, P. Tsao, L. Bruhn, and T. Quertermous Molecular Signatures Determining Coronary Artery and Saphenous Vein Smooth Muscle Cell Phenotypes: Distinct Responses to Stimuli Arterioscler Thromb Vasc Biol, May 1, 2006; 26(5): 1058 - 1065. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Oksjoki, P. T. Kovanen, K. A. Lindstedt, B. Jansson, and M. O. Pentikainen OxLDL-IgG Immune Complexes Induce Survival of Human Monocytes Arterioscler Thromb Vasc Biol, March 1, 2006; 26(3): 576 - 583. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Conway and M. Kinter Proteomic and Transcriptomic Analyses of Macrophages with an Increased Resistance to Oxidized Low Density Lipoprotein (oxLDL)-induced Cytotoxicity Generated by Chronic Exposure to oxLDL Mol. Cell. Proteomics, October 1, 2005; 4(10): 1522 - 1540. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Negishi, H. Shimizu, S. Okada, A. Kuwabara, F. Okajima, and M. Mori 9HODE Stimulates Cell Proliferation and Extracellular Matrix Synthesis in Human Mesangial Cells via PPAR{gamma} Experimental Biology and Medicine, November 1, 2004; 229(10): 1053 - 1060. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Zettler, M. A. Prociuk, J. A. Austria, G. Zhong, and G. N. Pierce Oxidized Low-Density Lipoprotein Retards the Growth of Proliferating Cells by Inhibiting Nuclear Translocation of Cell Cycle Proteins Arterioscler Thromb Vasc Biol, April 1, 2004; 24(4): 727 - 732. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B Gonzalez-Timon, M Gonzalez-Munoz, C Zaragoza, S Lamas, and E.M Melian Native and oxidized low density lipoproteins oppositely modulate the effects of insulin-like growth factor I on VSMC Cardiovasc Res, February 1, 2004; 61(2): 247 - 255. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. Sedgwick, Y. S. Hwang, H. A. Gerbyshak, H. Kita, and W. W. Busse Oxidized Low-Density Lipoprotein Activates Migration and Degranulation of Human Granulocytes Am. J. Respir. Cell Mol. Biol., December 1, 2003; 29(6): 702 - 709. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Q. Nhan, W. C. Liles, A. Chait, J. T. Fallon, and S. M. Schwartz The p17 Cleaved Form of Caspase-3 Is Present Within Viable Macrophages In Vitro and in Atherosclerotic Plaque Arterioscler Thromb Vasc Biol, July 1, 2003; 23(7): 1276 - 1282. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Zettler, M. A. Prociuk, J. A. Austria, H. Massaeli, G. Zhong, and G. N. Pierce OxLDL stimulates cell proliferation through a general induction of cell cycle proteins Am J Physiol Heart Circ Physiol, February 1, 2003; 284(2): H644 - H653. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. GOUNI-BERTHOLD and A. SACHINIDIS Does the coronary risk factor low density lipoprotein alter growth and signaling in vascular smooth muscle cells? FASEB J, October 1, 2002; 16(12): 1477 - 1487. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. M. Ananyeva, D. V. Kouiavskaia, M. Shima, and E. L. Saenko Intrinsic pathway of blood coagulation contributes to thrombogenicity of atherosclerotic plaque Blood, May 29, 2002; 99(12): 4475 - 4485. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Hundal, B. S. Salh, J. W. Schrader, A. Gomez-Munoz, V. Duronio, and U. P. Steinbrecher Oxidized low density lipoprotein inhibits macrophage apoptosis through activation of the PI 3-kinase/PKB pathway J. Lipid Res., September 1, 2001; 42(9): 1483 - 1491. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Steinerova, F. Stozicky, J. Racek, F. Tatzber, T. Zima, and R. Setina Antibodies against Oxidized LDL in Infants Clin. Chem., June 1, 2001; 47(6): 1137 - 1138. [Full Text] [PDF]
|
|
|
|
|
|
A. Pirillo, G. D. Norata, T. Zanelli, and A. L. Catapano Overexpression of Inducible Heat Shock Protein 70 in COS-1 Cells Fails to Protect From Cytotoxicity of Oxidized LDLs Arterioscler Thromb Vasc Biol, March 1, 2001; 21(3): 348 - 354. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.-S. Lee and L.-Y. Chau Fas/Fas ligand-mediated death pathway is involved in oxLDL-induced apoptosis in vascular smooth muscle cells Am J Physiol Cell Physiol, March 1, 2001; 280(3): C709 - C718. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-C. Hsieh, M.-H. Yen, C.-H. Yen, and Y.-T. Lau Oxidized low density lipoprotein induces apoptosis via generation of reactive oxygen species in vascular smooth muscle cells Cardiovasc Res, January 1, 2001; 49(1): 135 - 145. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Okura, M. Brink, H. Itabe, K. J. Scheidegger, A. Kalangos, and P. Delafontaine Oxidized Low-Density Lipoprotein Is Associated With Apoptosis of Vascular Smooth Muscle Cells in Human Atherosclerotic Plaques Circulation, November 28, 2000; 102(22): 2680 - 2686. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Mietus-Snyder, M. S. Gowri, and R. E. Pitas Class A Scavenger Receptor Up-regulation in Smooth Muscle Cells by Oxidized Low Density Lipoprotein. ENHANCEMENT BY CALCIUM FLUX AND CONCURRENT CYCLOOXYGENASE-2 UP-REGULATION J. Biol. Chem., June 2, 2000; 275(23): 17661 - 17670. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Klouche, S. Rose-John, W. Schmiedt, and S. Bhakdi Enzymatically Degraded, Nonoxidized LDL Induces Human Vascular Smooth Muscle Cell Activation, Foam Cell Transformation, and Proliferation Circulation, April 18, 2000; 101(15): 1799 - 1805. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Rusinol, L. Yang, D. Thewke, S. R. Panini, M. F. Kramer, and M. S. Sinensky Isolation of a Somatic Cell Mutant Resistant to the Induction of Apoptosis by Oxidized Low Density Lipoprotein J. Biol. Chem., March 15, 2000; 275(10): 7296 - 7303. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Mehrabi, H. Sinzinger, C. Ekmekcioglu, F. Tamaddon, K. Plesch, H. D Glogar, G. Maurer, T. Stefenelli, and I. M. Lang Accumulation of oxidized LDL in human semilunar valves correlates with coronary atherosclerosis Cardiovasc Res, March 1, 2000; 45(4): 874 - 882. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Patel, Y. Shi, R. Niculescu, E. H. Chung, J. L. Martin, and A. Zalewski Characteristics of Coronary Smooth Muscle Cells and Adventitial Fibroblasts Circulation, February 8, 2000; 101(5): 524 - 532. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kamenz, W. Seibold, M. Wohlfrom, S. Hanke, N. Heise, C. Lenz, and H. Hanke Incidence of intimal proliferation and apoptosis following balloon angioplasty in an atherosclerotic rabbit model Cardiovasc Res, February 1, 2000; 45(3): 766 - 776. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Lehtolainen, M. Takeya, and S. Yla-Herttuala Retrovirus-Mediated, Stable Scavenger-Receptor Gene Transfer Leads to Functional Endocytotic Receptor Expression, Foam Cell Formation, and Increased Susceptibility to Apoptosis in Rabbit Aortic Smooth Muscle Cells Arterioscler Thromb Vasc Biol, January 1, 2000; 20(1): 52 - 60. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Koba, R. Pakala, T. Watanabe, T. Katagiri, and C. R. Benedict Vascular smooth muscle proliferation: Synergistic interaction between serotonin and low density lipoproteins J. Am. Coll. Cardiol., November 1, 1999; 34(5): 1644 - 1651. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C. M. Siow, J. P. Richards, K. C. Pedley, D. S. Leake, and G. E. Mann Vitamin C Protects Human Vascular Smooth Muscle Cells Against Apoptosis Induced by Moderately Oxidized LDL Containing High Levels of Lipid Hydroperoxides Arterioscler Thromb Vasc Biol, October 1, 1999; 19(10): 2387 - 2394. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Auge, M. Nikolova-Karakashian, S. Carpentier, S. Parthasarathy, A. Negre-Salvayre, R. Salvayre, A. H. Merrill Jr., and T. Levade Role of Sphingosine 1-Phosphate in the Mitogenesis Induced by Oxidized Low Density Lipoprotein in Smooth Muscle Cells via Activation of Sphingomyelinase, Ceramidase, and Sphingosine Kinase J. Biol. Chem., July 30, 1999; 274(31): 21533 - 21538. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Alcouffe, S. Caspar-Bauguil, V. Garcia, R. Salvayre, M. Thomsen, and H. Benoist Oxidized low density lipoproteins induce apoptosis in PHA-activated peripheral blood mononuclear cells and in the Jurkat T-cell line J. Lipid Res., July 1, 1999; 40(7): 1200 - 1210. [Abstract] [Full Text]
|
|
|
|
|
|
G. Lizard, S. Monier, C. Cordelet, L. Gesquiere, V. Deckert, S. Gueldry, L. Lagrost, and P. Gambert Characterization and Comparison of the Mode of Cell Death, Apoptosis Versus Necrosis, Induced by 7ß-Hydroxycholesterol and 7-Ketocholesterol in the Cells of the Vascular Wall Arterioscler Thromb Vasc Biol, May 1, 1999; 19(5): 1190 - 1200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Bonderman, E. Gharehbaghi-Schnell, G. Wollenek, G. Maurer, H. Baumgartner, and I. M. Lang Mechanisms Underlying Aortic Dilatation in Congenital Aortic Valve Malformation Circulation, April 27, 1999; 99(16): 2138 - 2143. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Jahangiri, I. B. Kovacs, C. D. Ridler, G. M. Rees, and P. Gorog Coronary artery surgery is associated with different forms of atherogenic lipoprotein modifications Ann. Thorac. Surg., March 1, 1999; 67(3): 652 - 656. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. E. D. van den Eijnden, J. T. van Noort, L. Hollaar, A. van der Laarse, and R. M. Bertina Cholesterol or Triglyceride Loading of Human Monocyte-Derived Macrophages by Incubation With Modified Lipoproteins Does Not Induce Tissue Factor Expression Arterioscler Thromb Vasc Biol, February 1, 1999; 19(2): 384 - 392. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C Newby and A. B Zaltsman Fibrous cap formation or destruction -- the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation Cardiovasc Res, February 1, 1999; 41(2): 345 - 360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R Bennett Apoptosis of vascular smooth muscle cells in vascular remodelling and atherosclerotic plaque rupture Cardiovasc Res, February 1, 1999; 41(2): 361 - 368. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Lutgens, E. D. de Muinck, P. J.E.H.M. Kitslaar, J. H.M. Tordoir, H. J.J. Wellens, and M. J.A.P. Daemen Biphasic pattern of cell turnover characterizes the progression from fatty streaks to ruptured human atherosclerotic plaques Cardiovasc Res, February 1, 1999; 41(2): 473 - 479. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Guijarro, L. M. Blanco-Colio, M. Ortego, C. Alonso, A. Ortiz, J. J. Plaza, C. Diaz, G. Hernandez, and J. Egido 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase and Isoprenylation Inhibitors Induce Apoptosis of Vascular Smooth Muscle Cells in Culture Circ. Res., September 7, 1998; 83(5): 490 - 500. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Kockx, G. R. Y. De Meyer, J. Muhring, W. Jacob, H. Bult, and A. G. Herman Apoptosis and Related Proteins in Different Stages of Human Atherosclerotic Plaques Circulation, June 16, 1998; 97(23): 2307 - 2315. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Murphy, N. Santanam, A. J. Morales, and S. Parthasarathy Lysophosphatidyl Choline, a Chemotactic Factor for Monocytes/T-Lymphocytes Is Elevated in Endometriosis J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 2110 - 2113. [Abstract] [Full Text]
|
|
|
|
|
|
M. Harada-Shiba, M. Kinoshita, H. Kamido, and K. Shimokado Oxidized Low Density Lipoprotein Induces Apoptosis in Cultured Human Umbilical Vein Endothelial Cells by Common and Unique Mechanisms J. Biol. Chem., April 17, 1998; 273(16): 9681 - 9687. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Jovinge, M. Crisby, J. Thyberg, and J. Nilsson DNA Fragmentation and Ultrastructural Changes of Degenerating Cells in Atherosclerotic Lesions and Smooth Muscle Cells Exposed to Oxidized LDL in Vitro Arterioscler Thromb Vasc Biol, October 1, 1997; 17(10): 2225 - 2231. [Abstract] [Full Text]
|
|
|
|
|
|
S. Seewald, G. Nickenig, Y. Ko, H. Vetter, and A. Sachinidis Low density lipoprotein enhances the thrombin-induced growth of vascular smooth muscle cells Cardiovasc Res, October 1, 1997; 36(1): 92 - 100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. J. Scheidegger, R. W. James, and P. Delafontaine Differential Effects of Low Density Lipoproteins on Insulin-like Growth Factor-1 (IGF-1) and IGF-1 Receptor Expression in Vascular Smooth Muscle Cells J. Biol. Chem., August 25, 2000; 275(35): 26864 - 26869. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||